Two important changes have been made to Medicare Part D in 2025 that may help make the cost of your prescription drugs more affordable and more manageable.
Continue Reading
Last call for comments for DM PFDD
TMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View…
Continue Reading
Dermatomyositis: A many-headed monster
The first-ever Externally Led Patient Focused Drug Development (EL-PFDD) meeting on June 7 offered a critical way for patients and their family members to highlight what life with DM is like.
Continue Reading
Raising the voice of patients in research
TMA medical advisor and patient advocate Ingrid de Groot insists patients be involved in medical research.
Continue Reading
Copay accumulator programs struck down
In a victory for patients, a federal judge recently struck down a policy that allowed health insurance plans to use copay accumulator and maximizer programs, thereby charging patients more for…
Continue Reading